Granules beats the commodity trap as JVs and finished dosages to propel growth
This article was originally published in Scrip
Executive Summary
Granules India says it is no run-of-the-mill active pharmaceutical ingredients (APIs) and pharmaceutical formulation intermediates (PFIs) player and that its business model has been built to beat the commodity trap.